OMC
AZN icon

Old Mission Capital’s AstraZeneca AZN Stock Holding History

Old Mission Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-119,004
Closed -$21.9M – 1078
2025
Q4 		$21.9M Buy
119,004
+89,184
+299% +$15.6M 0.5% 24
2025
Q3 		$4.58M Buy
29,820
+26,781
+881% +$4.05M 0.09% 130
2025
Q2 		$425K Sell
3,039
-69,062
-96% -$9.68M 0.01% 776
2025
Q1 		$10.6M Buy
72,101
+70,129
+3,556% +$10.1M 0.14% 62
2024
Q4 		$258K Sell
1,972
-225,879
-99% -$31.6M ﹤0.01% 809
2024
Q3 		$35.5M Buy
227,851
+208,270
+1,064% +$33.6M 0.51% 41
2024
Q2 		$3.05M Buy
+19,581
New +$2.95M 0.05% 241
2024
Q1 		– Sell
-38,601
Closed -$5.2M – 1292
2023
Q4 		$5.2M Buy
38,601
+27,684
+254% +$3.6M 0.1% 177
2023
Q3 		$1.48M Sell
10,917
-100,640
-90% -$13.7M 0.03% 371
2023
Q2 		$16M Sell
111,557
-86,258
-44% -$12.7M 0.34% 58
2023
Q1 		$27.5M Buy
197,815
+83,390
+73% +$11.2M 0.54% 37
2022
Q4 		$15.5M Sell
114,425
-6,161
-5% -$773K 0.44% 43
2022
Q3 		$13.2M Buy
120,586
+36,762
+44% +$4.66M 0.42% 33
2022
Q2 		$11.1M Buy
+83,824
New +$11M 0.31% 52
2021
Q3 		– Sell
-228,216
Closed -$27.3M – 984
2021
Q2 		$27.3M Buy
228,216
+91,378
+67% +$10M 0.93% 13
2021
Q1 		$13.6M Sell
136,838
-184,419
-57% -$18.5M 0.76% 22
2020
Q4 		$32.1M Buy
321,257
+252,087
+364% +$26.7M 1.98% 9
2020
Q3 		$7.58M Buy
+69,170
New +$7.69M 0.6% 37
2020
Q2 		– Sell
-35,366
Closed -$3.16M – 487
2020
Q1 		$3.16M Sell
35,366
-204,479
-85% -$19.2M 0.27% 86
2019
Q4 		$23.9M Buy
239,845
+81,971
+52% +$7.72M 1.84% 9
2019
Q3 		$14.1M Buy
+157,874
New +$13.7M 1.75% 9
2017
Q1 		– Sell
-47,309
Closed -$2.58M – 337
2016
Q4 		$2.58M Buy
+47,309
New +$2.69M 0.2% 82

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Old Mission Capital's AZN Position: Q1 2026 in Review

Old Mission Capital sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 119,004 shares — an estimated $21.9M sold.

Old Mission Capital first reported a position in AZN in Q4 2016 and held it in 22 quarters. The position peaked at $35.5M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Old Mission Capital reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Old Mission Capital sold 119,004 AstraZeneca shares in Q1 2026, an estimated $21.9M.
  • Old Mission Capital first reported a position in AstraZeneca in Q4 2016 and held it in 22 quarters.
  • Old Mission Capital's AstraZeneca position peaked at $35.5M in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.